- -
- -
- 0
6 ABCL mentions in 30 days, more than any other subreddit.
Over the past week, AbCellera Biologics (ABCL) pulled in 118 mentions across Reddit, X and News. The read is an Adanos Hold. The crowd average is 22% bullish. Wall Street is more constructive, with 10 of 11 analysts rating ABCL a buy. ABCL does not read clearly more bullish or bearish than usual this week. Its Adanos Score is 65.4 out of 100, a Hold.
42.3out of 100
22%Spread 3 pts
118
Prices run to Nov 06, 2026. The sentiment can be newer. AbCellera Biologics (ABCL) buzz ended the 30 days at 24.4 while the price drifted down 5.3% across the period. Average daily volume over the 21 sessions is 3.6M shares. Updated Nov 07, 2026. Over the last 7 sessions, ABCL lost 9.2%. Buzz in those sessions averaged 47.5 and was highly volatile, swinging between 24.4 and 74.1. Recent volume is running below the 30-day average. Daily crowd sentiment leaned bullish on 20 of the 21 days with directional mentions.
ABCL scores 65.4 out of 100. A Buy needs 70 or more. Reddit is not counted this week. It has no bullish and bearish shares. Confidence is medium. Only 2 sources carry weight this week.
Wall Street’s 91% buy share sits next to a crowd that ranges from News at 20% to X at 23%.
+44.5% from the last close to the average target
11 analysts cover ABCL with a Strong Buy consensus. 10 rate it a buy and 0 a sell. Their average 12-month target is $17.17.
Analysts sit 69 points above the crowd average of 22%. Inside the crowd, X reads 23% bullish and News 20%, a 3-point spread.
6 ABCL mentions in 30 days, more than any other subreddit.
“$IBRX: the operating system of the immune system $NAUT: the $TSLA of proteomics $RXRX: superhuman Biology-Chemistry AI $ABCL: the machine t…”
“AbCellera (ABCL) Stock May Look Fully Priced On Book Value AbCellera Biologics has produced a sharp year to date gain, which naturally rais…” MarketBeat and Financial Post lead the coverage.
No Polymarket data for this stock this week.
See the Polymarket Top 50Based on aggregated sentiment from X and News, AbCellera Biologics (ABCL) carries an Adanos hold signal with an Adanos Score of 65.4 out of 100. Confidence is medium. Only 2 sources carry weight this week. The crowd average reads 22% bullish across 2 active sources. Over the last 7 days those sources carry 118 mentions. This is a sentiment-based reading, not financial advice.
Reddit has no mentions of AbCellera Biologics (ABCL) over the last 7 days. Over 30 days the discussion spans 6 subreddits.
AbCellera Biologics (ABCL) does not read clearly more bullish or bearish than usual this week, with an Adanos Score of 65.4 out of 100. In plain shares the crowd average is 22% bullish across 2 tracked sources over the last 7 days. The two ends of the range are X at 23% bullish and News at 20%, a 3-point spread. On Wall Street, 10 of 11 analysts rate ABCL a buy.
Of the 11 analysts covering AbCellera Biologics (ABCL), 10 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $17.17. That puts Wall Street ahead of the crowd average of 22% bullish.
AbCellera Biologics (ABCL)'s crowd average is 22% bullish. X reads 23% bullish and News is the most negative at 20% bullish. X reads clearly more bullish than usual. News reads more bearish than usual. Confidence is medium. Only 2 sources carry weight this week.
ABCL scores 65.4 out of 100. A Buy needs 70 or more. Reddit is not counted this week. It has no bullish and bearish shares. Confidence is medium. Only 2 sources carry weight this week. X reads clearly more bullish than usual. News reads more bearish than usual.
X is the dominant discussion channel with 113 mentions (96% of all mentions). News adds 5 mentions. The crowd average is 22% bullish, while X and News show rising 3-day activity. X reads clearly more bullish than usual. News reads more bearish than usual.
Each source's lean is its bullish share minus its bearish share. The Adanos Score compares it with that source's usual lean and weighs busier sources more. It runs from 0 to 100 with 50 as neutral. 70 or more reads Buy and 30 or less reads Sell. Everything between is Hold. Under 10 mentions and trades a stock stays at Hold. ABCL scores 65.4 out of 100 this week, so it reads Hold. It is a research shortcut, not financial advice.
Adanos rebuilds the ABCL page once a week. When someone opens it while its sentiment is more than 24 hours old, a background update fetches fresh Reddit, X, News and Polymarket readings and the latest daily prices. The next visit shows them. Company facts and analyst ratings update with the weekly rebuild. The sentiment figures cover the last 7 days.